Neovacs, of Paris, appointed Florence Hocdee-Leroy communications and investor relations director...Oligomerix Inc., of New York, appointed Vic Micati chairman and named Jack Pasini chief commercial officer and board member

Cytogenix Inc., of New York, appointed Kevin Cassidy and Campbell Murray to its board...Generex Biotechnology Corp., of Worcester, Mass., appointed Mark Fletcher interim president and CEO and named John P. Barratt chairman

Accera Inc., of Broomfield, Colo., appointed Thomas Werner president and CEO...Agile Therapeutics Inc., of Princeton, N.J., named Al Altomari president and CEO...AIKO Biotechnology, of Portland, Maine, appointed Jim New CEO and added Paul Goldenheim to its board

in Europe, Asia and Latin America...He previously served as executive vice president of Abbott Corp., of Abbott Park, Ill., and president of its pharmaceutics division, in addtion to group president for Europe and subsequently president of Abbott International

to chief operating officer and David R. Holland to senior vice president of sales and marketing...Myers, Fla., appointed Grant Carlson vice president of business development and named Mark W. Smits vice president of sales and marketing effective Aug. 30, 2010

plc, of Dublin, Ireland, appointed Colin W. Stewart president, CEO and a member of the company's board, effective Aug. 16...Selecta Biosciences Inc., of Watertown, Mass., appointed Werner Cautreels president and CEO...Cautreels most recently served as CEO and global head of R&D at Solvay Pharmaceuticals Inc., acquired earlier this year by Abbott, of Abbott Park, Ill. (See BioWorld Today, Sept. 29, 2009

Celsion Corp., of Columbia, Md., appointed Sid Taubenfeld director of communications and strategic initiatives and named Robert W. Hooper to its board...Dynavax Technologies Corp., of Berkeley, Calif., promoted J. Tyler Martin to president and appointed him to the board

The firm also appointed Ronald Evans and David Mangelsdorf to its scientific advisory board

plc, of Dublin, Ireland, named Eliseo Oreste Salinas executive vice president and chief medical officer...Ikaria Inc., of Clinton, N.J., appointed Martin Meglasson chief science officer, and named Craig Tooman senior vice president and chief financial officer...Hueneme, Calif., appointed Malcolm Gefter to its board and scientific advisory board

Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Julie A. Caudill vice president of finance and corporate controller...Ambit Biosciences Corp., of San Diego, appointed Alan J. Lewis chairman and CEO...Lewis, who most recently served as president and CEO of the Juvenile Diabetes Research Foundation, has been serving as Ambit's executive chairman since March

The Foundation for the National Institutes of Health appointed Scott Campbell director and CEO...Taris Biomedical Inc., of Lexington, Mass., appointed Sarma Duddu president, CEO and a member of its board...Most recently, Duddu was general manager and vice president of worldwide drug delivery technologies at CIMA Labs Inc, a wholly owned subsidiary of Cephalon Inc., of Frazer, Pa

Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...Bioheart Inc., of Sunrise, Fla., appointed Mike Tomas president, CEO and board member, replacing Karl Groth, who will retain his position as chairman...Jennerex Inc., of San Francisco, appointed Gregory W. Schafer senior vice president and chief financial officer

Novavax Inc., of Rockville, Md., appointed John W. Madsen head of process and manufacturing operations and named Steven Pincus head of analytical and quality operations...Probiodrug AG, of Halle, Germany, appointed Claus Braestrup chairman and named Lennart Mucke to its scientific advisory board

CombiMatrix Corp., of Mukilteo, Wash., named Mark McGowan interim president and CEO, effective July 1...Cyntellect Inc., of San Diego, appointed Saiid Zarrabian president and CEO...and Jonathan M. Spergel to its scientific advisory board

Algeta ASA, of Oslo, Norway, elected Judith Hemberger and Kapil Dhingra to its board of directors...Amgen Inc., of Thousand Oaks,Calif., appointed Robert A. Bradway president and chief operating officer...CMDBioscience, of Orange, Conn., appointed Erick Suchanek and Bernhardt Trout to its scientific advisory board

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., has appointed Richard King president and CEO...Previously, King was president and general manager of Tercica Inc., which was acquired by Ipsen SA, of Paris, in 2008...Oxigene Inc., of South San Francisco, appointed Tamar Howson and its CEO Peter J. Langecker, to its board of directors

Semprus BioSciences Inc, of Cambridge, Mass., appointed Colin R. Gardner and Michael J. Cima to its scientific advisory board...Spectral Diagnostics Inc., of Toronto, appointed Kevin Giese and Laine Woollard to its board...TrovaGene Inc., of San Diego, named Andreas Braun vice president and chief medical officer

Afraxis, of San Diego, appointed David Campbell chief scientific officer and named Carmine Stengone vice president of corporate development...EUSA Pharma, of Oxford, UK, named Iain McGill president, Europe and International...GeoVax Labs Inc., of Smyrna, Ga., added Steven Antebi and David A. Dodd to its board

Arlen, who initially had joined the firm in July 2008 as president and chief medical officer, spent 11 years at the National Cancer Institute before joining Neogenix...IBio Inc., of Newark, Del., appointed Philip K. Russell to its board and named Vidadi Yusibov chief scientific officer